Company
CASPR
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
CASPR Biotech pioneers next-generation molecular diagnostics by harnessing CRISPR and novel Cas enzymes. Their portable, low-cost platform enables rapid detection of infectious diseases and antimicrobial resistance, delivering results in under an hour without the need for centralized laboratories.
Loading relationship preview